|
New AUA Guideline (2024): Salvage Therapy for Prostate Cancer Webcast (2024) |
|
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
|
|
$0.00 |
The course details the 2024 AUA Guidelines for salvage therapy following initial treatment of localized prostate cancer, focusing on integral aspects of salvage treatments, risk stratification and advanced imaging. Participants will gain insights into the timing and appropriate use of salvage radiation therapy with or without androgen deprivation therapy (ADT), the use of risk stratification tools and the application of next-generation imaging in patients with biochemical recurrence. |
|
Non-Muscle Invasive Bladder Cancer: Expert Guidance for Advanced Practice Providers (2024) |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
12/12/2024 |
$0.00 |
COMPLIMENTARY CME LIVE VIRTUAL COURSE!Join the AUA for Non-Muscle Invasive Bladder Cancer: Expert Guidance for Advanced Practice Providers (2024), featuring a dynamic live webinar tailored specifically for APPs. |
|
Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists - English (2024) |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
12/19/2024 |
$0.00 |
COMPLIMENTARY CME LIVE VIRTUAL COURSE!Join the AUA for Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists - English (2024), featuring a dynamic live webinar tailored specifically for Urologists and presented in English. |
|
Novel Imaging for Genitourinary Cancers – Diagnostics and Theranostics Podcast (2023) |
|
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation
|
|
$0.00 |
Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on: |
|
Oral Board Review Course (2025) |
|
|
02/22/2025 |
$2,330.00 |
Saturday Session- SOLD OUTSunday Session- Only A Few Spots Remain, Register Now!The 2025 AUA Oral Board Review Course will take place as a live virtual course. |
|
Oral Board Study Guide App (2023) (iOS and Android) |
|
|
|
$299.00 |
The AUA Oral Board Study Guide App features 78 interactive protocols in 37 topic areas. Developed by leading experts in urology, the app has been specifically designed for urologists preparing to take this examination and includes a strong emphasis on AUA Guidelines with direct access to the AUA Guidelines and the AUA Urology Core Curriculum for AUA members. Available for use on Apple and Android devices! Simply purchase access from AUA, download the app and then sign in with your AUA ID number. |
|
Overactive Bladder Update (2024): Expert Guidance for APPs |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
12/03/2024 |
$0.00 |
COMPLIMENTARY CME LIVE VIRTUAL COURSE! |
|
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. |
|
PARPi: Management of Adverse Events Webcast (2024) |
|
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Non-Physician Participation
|
|
$0.00 |
The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered. |
|
Patient Safety Course (2024) |
|
|
|
$0.00 |
The Patient Safety Course is designed to provide urologists and the urology care team with the knowledge required to apply appropriate patient safety procedures in a urologic practice. Urology specific examples will help learners understand patient safety concepts, how safety issues arise, and how they can be mitigated. |
|
Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024) |
|
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
|
|
$0.00 |
Learners will be presented with case-based and guidelines-based information regarding when to introduce third-line therapies to patients for potentially refractory overactive bladder (OAB), presentation (scripting) techniques to impart important information to patients with user-friendly comprehensible language and analogies to help the patients receive the counseling, pros and cons of each of the third-line therapies, technical tips on optimal delivery of the three third-line therapies and how to select which therapies are the best fit for a given patient. |
|
Practice Management & Coding Program Webcast (2022) |
|
|
|
$1,095.00 |
Management, Leadership and Coding for Your Urology Practice! This two session webcast combines the AUA’s ever popular Practice Management Conference and annual Coding Seminar into one comprehensive course offering. The purpose of this webcast is to educate physicians and non-physicians alike on the topics impacting the management of today’s urology practice with an increased emphasis on coding and reimbursement. |
|
Practice Management Program Webcast (2021) |
|
|
|
$299.00 |
Complimentary Webcast for AUA Members and Practice Managers' Network Subscribers! |
|
Prostate Cancer Diagnosis: AUA Guidelines on use of PSA Biomarkers, MRI and Biopsy Techniques Webcast (2024) |
|
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Non-Physician Participation
|
|
$0.00 |
Prostate cancer detection remains one of the most common and most controversial aspects of urological practice. In addition to the complexities around screening and use of PSA, the role of other biomarkers, biopsy techniques such as transperineal biopsy and MRI for targeted biopsy are evolving rapidly. This course is intended for urologists, advanced practice providers and trainees interested in using the most evidence-based methods for optimizing detection of clinically important prostate cancers, while improving patient experience and minimizing complications. |
|
Prostate Cancer Update (2024): Expert Guidance for APPs Webcast |
|
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Non-Physician Participation
|
|
$0.00 |
|
Facebook
Twitter
LinkedIn
Forward